共 50 条
- [31] Loss of either p16/CDKN2 or retinoblastoma is required for overcoming senescence in human prostate epithelial cells. [J]. JOURNAL OF UROLOGY, 1998, 159 (05): : 71 - 71
- [33] Absence of p16 gene (CDKN2) deletions in microdissected primary breast carcinoma specimens [J]. Annals of Surgical Oncology, 1997, 4 : 416 - 420
- [35] REPLACEMENT OF THE P16/CDKN2 GENE SUPPRESSES HUMAN GLIOMA CELL-GROWTH [J]. CANCER RESEARCH, 1995, 55 (06) : 1351 - 1354
- [40] P16 immunohistochemistry is a sensitive and specific surrogate marker for CDKN2A homozygous deletion in gliomas [J]. Acta Neuropathologica Communications, 11